Q2 2026 saw revenue decline 3% year-over-year, with North America returning to organic growth and Specialty segment growth offset by European weakness due to ERP issues. Adjusted EPS and net income fell, and 2026 guidance was revised downward, reflecting a slower European recovery and ongoing strategic review.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.